Navigating the 49th parallel: Cross-border structuring strategies for Canadian life sciences and healthtech companies

​Are you building a Canadian life sciences or healthtech company with one eye firmly set on the U.S. market? The decisions you make today about your corporate structure and tax planning could define your company's trajectory for years to come. Join Torys and OBIO® for an exclusive breakfast discussion, followed by networking. The panel discussion will share practical insights drawn from real transactions and help you ask the right questions when considering cross-border structuring.

​

​This session will unpack the cross-border structuring and tax considerations that impact every venture-backed founder, such as:

• ​how does raising U.S. capital affect CCPC status (and the valuable tax advantages that come with it);

• ​why do U.S. investors ask Canadian companies to move to the U.S. and what does that mean for how you structure your cap table; and

• ​what is a Qualified Small Business Stock (QSBS).

​Seats are limited. Breakfast will be served. Bring your appetite, and questions, and come ready for a frank conversation about how to structure your company for success on both sides of the border.